This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1eve
From Proteopedia
(Difference between revisions)
m (Protected "1eve" [edit=sysop:move=sysop]) |
|||
| Line 34: | Line 34: | ||
*[[Acetylcholinesterase 3D structures|Acetylcholinesterase 3D structures]] | *[[Acetylcholinesterase 3D structures|Acetylcholinesterase 3D structures]] | ||
*[[Acetylcholinesterase: Treatment of Alzheimer's disease|Acetylcholinesterase: Treatment of Alzheimer's disease]] | *[[Acetylcholinesterase: Treatment of Alzheimer's disease|Acetylcholinesterase: Treatment of Alzheimer's disease]] | ||
| + | *[[Aricept Complexed with Acetylcholinesterase|Aricept Complexed with Acetylcholinesterase]] | ||
*[[Huperzine A Complexed with Acetylcholinesterase|Huperzine A Complexed with Acetylcholinesterase]] | *[[Huperzine A Complexed with Acetylcholinesterase|Huperzine A Complexed with Acetylcholinesterase]] | ||
*[[Joel Sussman's Favorites|Joel Sussman's Favorites]] | *[[Joel Sussman's Favorites|Joel Sussman's Favorites]] | ||
Revision as of 16:28, 14 July 2017
THREE DIMENSIONAL STRUCTURE OF THE ANTI-ALZHEIMER DRUG, E2020 (ARICEPT), COMPLEXED WITH ITS TARGET ACETYLCHOLINESTERASE
| |||||||||||

